Skip to main content
Medicine LibreTexts

8.7: References

  1. Last updated
  2. Save as PDF
  • Page ID
    104559

    • \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    \( \newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\)

    ( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\id}{\mathrm{id}}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\kernel}{\mathrm{null}\,}\)

    \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\)

    \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\)

    \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\AA}{\unicode[.8,0]{x212B}}\)

    \( \newcommand{\vectorA}[1]{\vec{#1}}      % arrow\)

    \( \newcommand{\vectorAt}[1]{\vec{\text{#1}}}      % arrow\)

    \( \newcommand{\vectorB}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vectorC}[1]{\textbf{#1}} \)

    \( \newcommand{\vectorD}[1]{\overrightarrow{#1}} \)

    \( \newcommand{\vectorDt}[1]{\overrightarrow{\text{#1}}} \)

    \( \newcommand{\vectE}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{\mathbf {#1}}}} \)

    \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    \(\newcommand{\avec}{\mathbf a}\) \(\newcommand{\bvec}{\mathbf b}\) \(\newcommand{\cvec}{\mathbf c}\) \(\newcommand{\dvec}{\mathbf d}\) \(\newcommand{\dtil}{\widetilde{\mathbf d}}\) \(\newcommand{\evec}{\mathbf e}\) \(\newcommand{\fvec}{\mathbf f}\) \(\newcommand{\nvec}{\mathbf n}\) \(\newcommand{\pvec}{\mathbf p}\) \(\newcommand{\qvec}{\mathbf q}\) \(\newcommand{\svec}{\mathbf s}\) \(\newcommand{\tvec}{\mathbf t}\) \(\newcommand{\uvec}{\mathbf u}\) \(\newcommand{\vvec}{\mathbf v}\) \(\newcommand{\wvec}{\mathbf w}\) \(\newcommand{\xvec}{\mathbf x}\) \(\newcommand{\yvec}{\mathbf y}\) \(\newcommand{\zvec}{\mathbf z}\) \(\newcommand{\rvec}{\mathbf r}\) \(\newcommand{\mvec}{\mathbf m}\) \(\newcommand{\zerovec}{\mathbf 0}\) \(\newcommand{\onevec}{\mathbf 1}\) \(\newcommand{\real}{\mathbb R}\) \(\newcommand{\twovec}[2]{\left[\begin{array}{r}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\ctwovec}[2]{\left[\begin{array}{c}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\threevec}[3]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\cthreevec}[3]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\fourvec}[4]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\cfourvec}[4]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\fivevec}[5]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\cfivevec}[5]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\mattwo}[4]{\left[\begin{array}{rr}#1 \amp #2 \\ #3 \amp #4 \\ \end{array}\right]}\) \(\newcommand{\laspan}[1]{\text{Span}\{#1\}}\) \(\newcommand{\bcal}{\cal B}\) \(\newcommand{\ccal}{\cal C}\) \(\newcommand{\scal}{\cal S}\) \(\newcommand{\wcal}{\cal W}\) \(\newcommand{\ecal}{\cal E}\) \(\newcommand{\coords}[2]{\left\{#1\right\}_{#2}}\) \(\newcommand{\gray}[1]{\color{gray}{#1}}\) \(\newcommand{\lgray}[1]{\color{lightgray}{#1}}\) \(\newcommand{\rank}{\operatorname{rank}}\) \(\newcommand{\row}{\text{Row}}\) \(\newcommand{\col}{\text{Col}}\) \(\renewcommand{\row}{\text{Row}}\) \(\newcommand{\nul}{\text{Nul}}\) \(\newcommand{\var}{\text{Var}}\) \(\newcommand{\corr}{\text{corr}}\) \(\newcommand{\len}[1]{\left|#1\right|}\) \(\newcommand{\bbar}{\overline{\bvec}}\) \(\newcommand{\bhat}{\widehat{\bvec}}\) \(\newcommand{\bperp}{\bvec^\perp}\) \(\newcommand{\xhat}{\widehat{\xvec}}\) \(\newcommand{\vhat}{\widehat{\vvec}}\) \(\newcommand{\uhat}{\widehat{\uvec}}\) \(\newcommand{\what}{\widehat{\wvec}}\) \(\newcommand{\Sighat}{\widehat{\Sigma}}\) \(\newcommand{\lt}{<}\) \(\newcommand{\gt}{>}\) \(\newcommand{\amp}{&}\) \(\definecolor{fillinmathshade}{gray}{0.9}\)

    Ajmal, M., Khan, M., & Van Fossen K. (2022, October 6). Breast fibroadenoma. StatPearls [Internet]. www.ncbi.nlm.nih.gov/books/NBK535345

    American Cancer Society. (2021a). Breast cancer hormone receptor status. https://www.cancer.org/cancer/types/...or-status.html

    American Cancer Society. (2021b). Breast cancer stages. https://www.cancer.org/cancer/types/...st-cancer.html

    American Cancer Society. (2021c). Breast reconstruction options. https://www.cancer.org/cancer/types/...n-options.html

    American Cancer Society. (2021d). Genetic counseling and testing for breast cancer risk. https://www.cancer.org/cancer/types/...c-testing.html

    American Cancer Society. (2021e). Immunotherapy for breast cancer. https://www.cancer.org/cancer/types/...notherapy.html

    American Cancer Society. (2021f). Radiation for breast cancer. https://www.cancer.org/cancer/types/...st-cancer.html

    American Cancer Society. (2022a). American Cancer Society recommendations for the early detection of breast cancer. https://www.cancer.org/cancer/types/...st-cancer.html

    American Cancer Society. (2022b). Intraductal papillomas of the breast. https://www.cancer.org/cancer/types/...apillomas.html

    American Cancer Society. (2022c). Pregnancy after breast cancer. https://www.cancer.org/cancer/types/...st-cancer.html

    American Cancer Society. (2023a). Hormone therapy for breast cancer. https://www.cancer.org/cancer/types/...st-cancer.html

    American Cancer Society. (2023b). Key statistics for breast cancer. https://www.cancer.org/cancer/types/...st-cancer.html

    American College of Obstetricians and Gynecologists. (2017, July; reaffirmed 2021). Practice Bulletin No. 179: Breast cancer risk assessment and screening in average-risk women. https://www.acog.org/clinical/clinic...age-risk-women

    Bajaj, A. (2020). Acutely inflamed mamilla—mastitis and abscess. Journal of Medical Research and Surgery, 1(3), 1–7. https://doi.org/10.52916/jmrs204012

    Bischof, E., Schwab, F. D., Margarint, E. L. G., Montavon, C., Zünti, I., Schollback, A., Schötzau, A., Hirschmann, A., Landin, J., Meier, C., Christian, K., & Vetter, M. Adherence to bone health guidelines in patience with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience. Bone Reports, 16, 102260. https://doi.org/10.1016/j.bonr.2021.101160

    Breastcancer.org. (2022a, June 29). Benign breast conditions. https://www.breastcancer.org/benign-breast-conditions

    Breastcancer.org. (2022b, July 27). Fibroadenoma. https://www.breastcancer.org/benign-...s/fibroadenoma

    Breastcancer.org. (2023). Breast cancer facts and statistics. https://www.breastcancer.org/facts-statistics

    Centers for Disease Control and Prevention. (2023). Cancer statistics at a glance. https://gis.cdc.gov/Cancer/USCS/#/AtAGlance/

    Chen, Y. Y., Fang, W. H., Wang, C. C., Kao, T. W., Chang, Y. W., Yang, H. F., Wu, C. J., Sun, Y. S., & Chen, W. L. (2018). Examining the associations among fibrocystic breast change, total lean mass, and percent body fat. Scientific Reports, 8(1), 9180. https://doi.org/10.1038/s41598-018-27546-3

    Costa Morais Oliveira, V., Cubas-Vega, N., López Del-Tejo, P., Baía-da-Silva, D. C., Araújo Tavares, M., Picinin Safe, I., Cordeiro-Santos, M., Lacerda, M. V. G., & Val, F. (2021). Non-lactational infectious mastitis in the Americas: A systematic review. Frontiers in Medicine, 8, 672513. https://doi.org/10.3389/fmed.2021.672513

    de Boniface, J., Szulkin, R., & Johansson, A. L. V. (2021). Survival after breast conservation vs mastectomy adjusted for comorbidity and socioeconomic status: A Swedish national 6-year follow-up of 48 986 women. JAMA Surgery, 156(7), 628–637. https://doi.org/10.1001/jamasurg.2021.1438

    Demarco, C. (2023, January 19). Side effects of radiation therapy for breast cancer. https://www.mdanderson.org/cancerwis...159615489.html

    El-Essawy, M., Haidary, A. A., & Khan, A. L. (2020, May 6). Ductal carcinoma in situ (DCIS) in breast fibroadenoma. Egyptian Journal of Radiology and Nuclear Medicine, 51(73). https://doi.org/10.1186/s43055-020-00191-5

    Gopalani, S. V., Janitz, A. E., Martinez, S. A., Gutman, P., Khan, S., & Campbell, J. E. (2020). Trends in cancer incidence among American Indians and Alaska Natives and non-Hispanic Whites in the United States, 1999–2015. Epidemiology (Cambridge, Mass.), 31(2), 205–213. doi.org/10.1097/EDE.0000000000001140

    Hasan, S., Chew, K. S., Balang, R. V., & Wong, S. S. L. (2023). Beyond the scars: A qualitative study on the experiences of mastectomy among young women with breast cancer in a country with crisis. BMC Women’s Health, 23(1), 596. https://link.springer.com/article/10...05-023-02734-0

    Li, J., Humphreys, K., Ho, P. J., Eriksson, M., Darai-Ramqvist, E., Lindström, L. S., Hall, P., & Czene, K. (2018). Family history, reproductive, and lifestyle risk factors for fibroadenoma and breast cancer. JNCI Cancer Spectrum, 2(3), pky051. https://doi.org/10.1093/jncics/pky051

    Mburu, W., Kulasingam, S., Hodges, J. S., & Virnig, B.A. (2022). Breast-conserving surgery versus mastectomy for older women with triple-negative breast cancer: Population-based study. Journal of Comparative Effectiveness Research, 11(13). doi.org/10.2217/cer-2021-0273

    McDowell, S. (2022, October 3). Breast cancer death rates are highest for Black women—again. https://www.cancer.org/research/acs-...men-again.html

    Memorial Sloan Kettering Cancer Center. (n.d.). Stages of breast cancer. https://www.mskcc.org/cancer-care/ty.../stages-breast

    Mouslim, M. C., Johnson, R. M., & Dean, L. T. (2020). Healthcare system distrust and the breast cancer continuum of care. Breast Cancer Research and Treatment, 180(1), 33–44. https://doi.org/10.1007/s10549-020-05538-0

    National Breast Cancer Foundation. (n.d.). Stages. https://www.nationalbreastcancer.org...ancer-staging/

    National Cancer Institute. (2023a). All cancer sites combined: Recent trends in SEER age-adjusted incidence rates, 2000–2020. https://seer.cancer.gov/statistics-n...plication.html

    National Cancer Institute. (2023b). SEER incidence data, 1975–2020. https://seer.cancer.gov/data/

    National Institute of Biomedical Imaging and Bioengineering. (n.d.). Mammography. https://www.nibib.nih.gov/science-ed...cs/mammography

    North American Menopause Society. (2023). Other body changes affecting sexuality. https://www.menopause.org/for-women/...ting-sexuality

    Nursing drug handbook. (2023). Wolters Kluwer.

    Oncology Nursing Society. (2018). Toolkit for safe handling of hazardous drugs for nurses in oncology. https://www.ons.org/sites/default/fi..._Toolkit_0.pdf

    Sarkar, D. K., Banerjee, R., Gupta, S., Singhal, A. K., & Halder, A. (2023). Management of idiopathic granulomatous mastitis: A prospective study. Annals of the Royal College of Surgeons of England, 105(3), 218–224. doi.org/10.1308/rcsann.2022.0017

    Stachs, A., Stubert, J., Reimer, T., & Hartmann, S. (2019, August 9). Benign breast disease in women. Deutsches Arzteblatt International, 116(33–34), 565–574. https://doi.org/10.3238/arztebl.2019.0565

    Stringer-Reasor, E. M., Elkhanany, A., Khoury, K., Simon, M. A., & Newman, L. A. (2021). Disparities in breast cancer associated with African American identity. American Society of Clinical Oncology Educational Book, 41, E29–246. doi.org/10.1200/EDBK_319929

    Susan G. Komen. (2022a). Breast cancer screening for women at average risk. https://www.komen.org/breast-cancer/...ecommendations

    Susan G. Komen. (2022b). Breast cancer screening for women at higher risk. https://www.komen.org/breast-cancer/...gh-risk-women/

    Susan G. Komen. (2023a). Chemotherapy drugs for early breast cancer. https://www.komen.org/breast-cancer/...therapy/drugs/

    Susan G. Komen. (2023b). Genetic testing to learn about breast cancer risk. https://www.komen.org/breast-cancer/...netic-testing/

    Susan G. Komen. (2023c). Race and ethnicity. https://www.komen.org/breast-cancer/...ace-ethnicity/

    Susan G. Komen. (2023d). Tumor characteristics: Hormone receptor status. https://www.komen.org/breast-cancer/...aracteristics/

    U. S. Preventive Services Task Force. (2016). Breast cancer: Screening. https://www.uspreventiveservicestask...ncer-screening

    Yadav, P., Sharma, A., Singh, L., & Gupta, R. (2020). Management of fibrocystic breast disease: A comprehensive review. Journal of Advanced Scientific Research, 11(4), 30–37. https://sciensage.info/index.php/JAS...ticle/view/552

    This page titled 8.7: References is shared under a CC BY 4.0 license and was authored, remixed, and/or curated by OpenStax via source content that was edited to the style and standards of the LibreTexts platform.